DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr | ₹624 Cr |
What is the latest Short Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹850 Cr |
| Mar2024 | ₹527 Cr |
| Mar2023 | ₹445 Cr |
| Mar2022 | ₹1,265 Cr |
| Mar2021 | ₹624 Cr |
How is Short Term Provisions of DIVIS LABORATORIES Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹850 Cr | 61.29 | |
| Mar2024 | ₹527 Cr | 18.43 | |
| Mar2023 | ₹445 Cr | -64.81 | |
| Mar2022 | ₹1,265 Cr | 102.56 | |
| Mar2021 | ₹624 Cr | - | |
Compare Short Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹181,888.7 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,911.0 Cr | -0.3% | 7.9% | 8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 4.2% |
3.9% |
1.5% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses